Sponsor Dossier
Vertex Pharmaceuticals
Sponsor Dossier for Vertex Pharmaceuticals. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
About
Vertex Pharmaceuticals is an Australian Private Company with ABN 34 160 157 157, registered in NSW and currently active.
Portfolio
Vertex Pharmaceuticals has 5 brands on the ARTG, with 5 brands cleared for indexing and 5 brands with Product Information on file. The portfolio includes ALYFTREK, KALYDECO, ORKAMBI, SYMDEKO, and TRIKAFTA. Five brands have PBAC outcomes on record and 3 brands have AusPARs on record. One brand is PBS-listed.
Therapeutic focus
— Respiratory: 3 brands — Rare Disease: 2 brands
PBS footprint
One brand in the portfolio is PBS-listed, with the latest schedule date touched on 1 May 2026.
Regulatory activity
The most recent PBAC outcome dates to 1 July 2025, with 5 brands holding PBAC outcomes on record. The latest AusPAR is dated 14 November 2025, with 3 brands holding AusPARs on record.